Posts by Mahdia Hashimy

Mahdia is a Research Analyst at PharmSource. She earned a BS degree in biology from George Mason University, where she minored in business. Prior to this, she received a magna cum laude honors Associates of Sciences degree from Northern Virginia Community College. Mahdia is avidly interested in clinical research and science.

PharmSource Coverage of ASCO 2017

Chicago hosted 30,000 American Society of Clinical Oncology (ASCO) conference visitors this weekend, including myself and fellow researcher Scotty Chung-Siu. You may have noticed the uptick in the PharmSource Lead Sheet recently, especially in Phase I & II studies. In fact, oncology leads hold 46% of this week’s PharmSource Lead Sheet, so be sure to […]

Learn more

CRISPR: Gene Therapy 2.0

It looks like 2017 will be an exciting year for the Biotech industry. One development that has caught much attention is the new generation of gene therapy, the CRISPR-Cas9 genome editing tool that with cautious optimism is expected to start a new wave of faster, more accurate treatment for monogenetic diseases through DNA modification. With […]

Learn more